WHO ICTRP trial
A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With…
PER-001-06 · Registro Peruano de Ensayos Clínicos (REPEC) · Not Recruiting
Key facts
| Trial ID | PER-001-06 |
|---|---|
| Public title | A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer |
| Scientific title | A Multicenter, Randomized Phase II, Partially Blind, Placebo-Controlled Study with Lapatinib in Patients with Locally Advanced Squamous Cell Head and Neck Caci |
| Primary sponsor | GLAXOSMITHKLINE BIOLOGICALS, |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | II |
| Countries | India;Spain;France;Greece;United Kindgdom;Brazil;Peru |
| Conditions | -C444 Skin of scalp and neck Skin of scalp and neck;C444;Skin of scalp and neck |
| Interventions | Group name:GROUP 1 Type of group;1 N° of participants:60 Intervention(s) description:This group will be treated with Lapatinib 1500 mg QD PO for a minimum of 2 weeks up to a maximum of 6 weeks. After this the patients will continue with the… |
| Registration date | Mar 24, 2006 |
| Target size | 12 |
| Secondary IDs | NA;NCT00371566;2005-002485-11-GB |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: